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Abstract
Background: RNA viruses are responsible for a variety of illnesses among people, including but
not limited to the common cold, the flu, HIV, and ebola. Developing new drugs and new strategies
for treating diseases caused by these viruses can be an expensive and time-consuming process.
Mathematical modeling may be used to elucidate host-pathogen interactions and highlight potential
targets for drug development, as well providing the basis for optimizing patient treatment
strategies. The purpose of this work was to determine whether a genome-scale modeling approach
could be used to understand how metabolism is impacted by the host-pathogen interaction during
a viral infection. Escherichia coli/MS2 was used as the host-pathogen model system as MS2 is easy to
work with, harmless to humans, but shares many features with eukaryotic viruses. In addition, the
genome-scale metabolic model of E. coli is the most comprehensive model at this time.
Results: Employing a metabolic modeling strategy known as "flux balance analysis" coupled with
experimental studies, we were able to predict how viral infection would alter bacterial metabolism.
Based on our simulations, we predicted that cell growth and biosynthesis of the cell wall would be
halted. Furthermore, we predicted a substantial increase in metabolic activity of the pentose
phosphate pathway as a means to enhance viral biosynthesis, while a break down in the citric acid
cycle was predicted. Also, no changes were predicted in the glycolytic pathway.
Conclusions: Through our approach, we have developed a technique of modeling virus-infected
host metabolism and have investigated the metabolic effects of viral infection. These studies may
provide insight into how to design better drugs. They also illustrate the potential of extending such
metabolic analysis to higher order organisms, including humans.
Background
Viruses are the cause of a variety of diseases ranging from
the mildly annoying common cold to the frighteningly
lethal ebola. Viruses infect their hosts and hijack the host
machinery, using it to produce more progeny viral parti-
cles. Viruses, being obligate parasites, require host
resources to replicate. Therefore, viral infections lead to
alterations in the metabolism of the host, shifting in favor
of viral protein production. A systems biology approach
for studying these metabolic changes in the host cell could
provide new insights to potential drug targets [1], moti-
vating this study.
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Systems biology deals with the studying of organisms that
are viewed as one collaborative network of genes, proteins
and other metabolites. Recent advancements in high-
throughput experimental techniques have brought a flood
of information in the form of genomic, transcriptomic,
proteomic and metabolomic datasets. Systems biology is
answering the growing need for the integration and inter-
pretation of these heterogeneous datasets. One of the
methodologies of systems biology, a constraints-based
modeling approach [2], has been successfully demon-
strated in identifying potential drug targets [3]. Genome-
scale metabolic models of disease-causing organisms have
been constructed and evaluated to identify potential drug
targets [3-5].
In this study, we have demonstrated the application of the
constraints-based, flux balance analysis approach to
investigate the effects of host-pathogen interactions on
host metabolism. The pathogen-host pair under consider-
ation was a bacterial virus, MS2, and its host, Escherichia
coli C-3000. MS2 is a lytic RNA bacteriophage, belonging
to the Leviviridae family of viruses and infects F+
Escherichia coli cells [6].
The Escherichia coli/MS2 system was chosen for a number
of reasons. MS2 is harmless to humans and yet possesses
many of the same features as its eukaryotic-infecting viral
cousins, and as a result may aid in our understanding of
RNA viruses in general. It can be cultured quickly, cheaply,
and safely, making it easy to work with. Furthermore, the
genome-scale metabolic model of E. coli is the most
exhaustive one to date. These factors combine to make the
E. coli/MS2 model system ideal for such a study.
The constraints-based modeling approach was used to
describe only a part of the infection process. Based on an
experimental study tracking the macromolecular synthe-
sis in MS2-infected Escherichia coli [7], the infection proc-
ess can be divided into 3 parts - an early transient period
where the infection process is initiated, a middle steady
state period where the viral protein synthesis has dis-
placed the host protein synthesis and a late transient
period where all biosynthesis has diminished and lysis is
approaching. This study used the constraints-based mod-
eling approach to investigate the middle steady state
period only.
The  Escherichia coli genome-scale metabolic model,
iAF1260 [8] was used as a basis to represent both - the
uninfected cells and the infected cells. C-3000, the
Escherichia coli strain used in this study and MG1655, the
Escherichia coli strain used to model iAF1260 are both
Escherichia coli K-12 derivatives. As a result, iAF1260 was
used to represent the uninfected cells. The genome-scale
metabolic model of MS2-infected E. coli was based on
iAF1260, but was modified to account for the viral infec-
tion process. The constraints for these models such as the
glucose uptake rate, the oxygen uptake rate and the
growth rates of the cells were measured experimentally.
Finally, the genome scale metabolomes of the infected
and the uninfected cells were compared to find what parts
of the metabolic network were activated, upregulated,
downregulated or deactivated.
Methods
For all in silico reconstructions, linear programming was
carried out using the GLPSOL (version 4.38) solver, which
is available as a part of the GNU Linear Programming Kit
[9]. In addition, to capture the effects of alternate optimal
solutions, flux variability analysis [10] was carried out for
all in silico reconstructions.
In silico reconstruction of genome-scale metabolic 
network of uninfected Escherichia coli
The reconstruction of the uninfected host metabolism was
based on the model iAF1260 [8]. In brief, the system was
defined as the metabolic network that included extracellu-
lar, cytoplasmic and periplasmic metabolites. Exchange
reactions were responsible for metabolites entering or
leaving the system. Transport reactions accounted for the
movement of metabolites across the inner and outer
membranes. The remaining reactions accounted for the
biochemical interactions among metabolites.
The constructed stoichiometric matrix ( ) of dimensions
m × n represented m number of metabolites and n number
of reactions. Each element of the matrix, Sij, represented
the stoichiometric coefficient of the ith metabolite in the jth
reaction. Flux balance analysis [2,11,12] was used to
determine the steady state flux distribution of the meta-
bolic network, mathematically represented by
where, v represented a vector of reaction fluxes. An opti-
mization technique, linear programming, was applied to
find a specific solution to the underdetermined linear
problem. Additional constraints in the form of bounds
were placed on each of the fluxes. For all the irreversible
reactions, the limits were 0 ≤ vi ≤ ∞ and for the reversible
reactions, the limits were -∞ ≤ vi ≤ ∞. For the exchange
fluxes, the limits of 0 ≤ vi ≤ ∞ were applied for the metab-
olites that were not present in the growth medium and the
limits of -∞ ≤ vi ≤ ∞ for the metabolites that were provided
by the growth medium. In addition, the fluxes of the lim-
iting reactions were constrained to the experimentally
measured values.
Based on studies that have systematically evaluated vari-
ous objective functions [13-15] on experimental systems
S
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similar to the one used in this study, maximization of ATP
yield was used to model the uninfected cells. Maximiza-
tion of ATP yield implies the maximization of the accu-
mulation of ATP in the metabolic network. The biological
rationale behind this approach is to account for the
requirement of ATP in the processes that are not included
in the metabolic model, such as mobility, futile cycles
[16] and heat generation. The allowance of accumulation
of ATP in the metabolic network would seem to be in con-
tradiction with the basic assumption of steady state of
metabolic networks, which implies that there is no accu-
mulation of metabolites. This issue was easily reconciled
by including an exchange reaction flux to represent ATP
requirements not directly accounted for in the metabolic
network as defined. Therefore, the objective function was
defined as the maximization of this exchange reaction.
In silico reconstruction of genome-scale metabolic 
network of infected Escherichia coli
To incorporate the effects of the bacteriophage infection,
a new subset of metabolites corresponding to the viral
proteins and the viral genome was added to the unin-
fected model. The MS2 bacteriophage encodes for four
proteins - coat protein, maturation protein, replicase pro-
tein and lysis protein. The MS2 bacteriophage genome is
a positive strand of RNA. The positive viral strands are
used as templates by the replicase protein to produce neg-
ative strands that further serve as templates to produce
positive viral strands [17]. As a result, the new subset of
metabolites consisted of the four viral proteins, positive
viral RNA and negative viral RNA. Reactions correspond-
ing to the formation of these viral metabolites from the
host metabolites were defined. In each of these reactions
the reactants were amino acids producing viral proteins or
nucleotides producing positive or negative viral RNA
strands. The stoichiometry of these reactions was based on
the amino acid sequence of the viral proteins or the nucle-
otide sequence of the MS2 genome. Exchange reactions
that transferred the viral metabolites out of the host sys-
tem were also included. A list of viral reactions and metab-
olites are presented in Table 1.
The regulated expression of viral genes was incorporated
in the infected cell model. This was achieved by fixing the
ratios of the fluxes of maturation protein production, rep-
licase protein production and lysis protein production to
coat protein production. The coat gene is expressed con-
stitutively and forms the major fraction of the viral pro-
teins that are produced [6,18,19]. The other viral proteins
are produced in much smaller amounts due to the regu-
Table 1: List of viral reactions and metabolites.
Name Description
Metabolic Reactions
viralA (35) ala-L + (29) arg-L + (17) asn-L + (13) asp-L + (3) cys-L + (18) gln-L + (17) glu-L + (28) gly + (5) his-L + (16) ile-L + 
(36) leu-L + (14) lys-L + (8) met-L + (16) phe-L + (17) pro-L + (36) ser-L + (27) thr-L + (12) trp-L + (16) tyr-L + (30) val-
L → mat_v
viralC (14) ala-L + (4) arg-L + (10) asn-L + (4) asp-L + (2) cys-L + (6) gln-L + (5) glu-L + (9) gly + (8) ile-L + (7) leu-L + (6) lys-L 
+ (3) met-L + (4) phe-L + (6) pro-L + (13) ser-L + (9) thr-L + (2) trp-L + (4) tyr-L + (14) val-L → coat_v
viralL (3) ala-L + (8) arg-L + (2) asn-L + asp-L + cys-L + (9) gln-L + (3) glu-L + his-L + (3) ile-L + (12) leu-L + (2) lys-L + met-L 
+ (5) phe-L + (4) pro-L + (6) ser-L + (9) thr-L + (2) tyr-L + (3) val-L → lys_v
viralR (41) ala-L + (42) arg-L + (18) asn-L + (33) asp-L + (7) cys-L + (15) gln-L + (22) glu-L + (44) gly + (10) his-L + (32) ile-L + 
(50) leu-L + (25) lys-L + (10) met-L + (28) phe-L + (27) pro- L + (48) ser-L + (31) thr-L + (9) trp-L + (21) tyr-L + (32) val- 
L → rep_v
viralposRNA (834) atp + (933) ctp + (927) gtp + (875) utp → posRNA_v
viralnegRNA (875) atp + (927) ctp + (933) gtp + (834) utp → negRNA_v
Exchange Reactions
EXviralA mat_v ↔
EXviralC coat_v ↔
EXviralL lys_v ↔
EXviralR rep_v ↔
EXviralposRNA posRNA_v ↔
EXviralnegRNA negRNA_v ↔
Viral Metabolites
mat_v viral maturation protein
coat_v viral coat protein
Lys_v viral lysis protein
rep_v viral replicase protein
posRNA_v positive sense viral RNA genome
negRNA_v negative sense viral RNA genomeBMC Systems Biology 2009, 3:121 http://www.biomedcentral.com/1752-0509/3/121
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lated expression of their corresponding genes [6]. Previ-
ous studies have shown that the amounts of each of the
maturation and replicase proteins were only 1/10th of that
of the coat protein [18,19]. As for the lysis protein, the
amount was found to be only 1/25th of that of the coat
protein [20]. These ratios were used in the model to
account for the regulated expression of the viral genes. The
ratios of fluxes corresponding to viral maturation protein
production, viral replicase protein production and viral
lysis protein production to viral coat protein production
were fixed to 1:10, 1:10 and 1:25, respectively.
Replication of the viral genome was also integrated into
the infected cell model by including the positive and neg-
ative viral RNA strands as metabolites and the correspond-
ing reactions that produce these metabolites. However, to
constrain the fluxes of these reactions, there has been no
experimental quantification of the number of positive
and negative strands per cell. Hence, the fluxes of the pro-
duction of these positive and negative strands were con-
strained based on the composition of MS2 virions. Each
MS2 virion consists of 180 copies of the coat protein and
one copy of the A protein and a positive strand of the viral
genome [6]. Therefore, the ratio of each of the fluxes of
positive and negative viral genomic RNA production to
the coat protein production was fixed to 1:180.
In addition to the application of constraints of the unin-
fected model, the exchange flux corresponding to the glu-
cose uptake rate was constrained to the experimentally
measured value of 12 mmol/g DW h. The growth rate and
the oxygen uptake rate of the host were bound by the lim-
its of 0 ≤ vi ≤ ∞ and -∞ ≤ vi ≤ ∞, respectively. Finally, appro-
priate objective functions were applied.
The most significant effect of the infection process is the
change in the objective of the metabolic network. The
objective function used to model the MS2 infected
Escherichia coli cells was to maximize the viral reaction
fluxes. The underlying reasoning for this approach was
that the virus is a parasite and takes over the machinery of
its host to produce viral components. Viral protein syn-
thesis dominates over the host protein synthesis [7].
Other objective functions considered were the simultane-
ous maximization of ATP yield and the viral fluxes, as well
as the simultaneous maximization of growth rate and the
viral fluxes. These objective functions resulted in no viral
protein production and therefore, were not considered
further in this study. This result reiterates the fact that host
protein synthesis has to be eclipsed for viral protein syn-
thesis to prevail.
Experimental methods
The experimental system consisted of the bacteriophage
MS2 (ATCC 15597-B1) and its host Escherichia coli C-3000
(ATCC 15597) in minimal M9 media [21] (supplemented
with 2 mM CaCl2 and 10 μg/ml thiamine). The experi-
mental methods used in this study were the same as
described previously [22]. In brief, for the uninfected
cells, C-3000 was grown in minimal M9 media at 37°C
(batch culture) and OD600 was measured using a Biomate
3 Spectrophotometer (Thermo Spectronic, Rochester,
NY), glucose concentrations were measured using a YSI
2700 Select Biochemical Analyzer (YSI, Yellow Springs,
OH) and dissolved oxygen was measured using a Dis-
solved Oxygen Meter SM600 (Milwaukee Instruments,
Inc, Rocky Mount, NC).
For the infected cells, a C-3000 culture in minimal M9
media at 37°C (batch culture) was infected with MS2
phage at an OD600 of 0.8 and an MOI of 10. OD600 and
glucose concentrations were measured. In addition, two
kinds of plaque assays were carried out as described in
previously published work [22]. The first method was
used to quantify the combined sum of infected cells and
free phages and started with the mixing of 100 μl of an
appropriately diluted sample of the culture with 3 ml E
medium (10 g/l of tryptone, 1 g/l of yeast extract and 8 g/
l of NaCl; also referred to as "EM") soft agar and 100 μl of
the plating culture (an overnight culture of Escherichia coli
C-3000). This mixture was poured on pre-warmed EM
plates and incubated overnight at 37°C. Plaques were
counted the next day. The second method was used to
quantify free phages only and was similar to the above
technique. The only differences were the use of Escherichia
coli C-3000+pBAD102 (ampicillin resistant) as the plating
culture and the addition of 100 g/ml ampicillin to EM soft
agar and EM plates. The presence of ampicillin did not
allow the infected cells to grow as they were ampicillin
sensitive. As a result, the plaques that were formed were
only due to the free phage. Utilizing both approaches
allowed for determination of free phage density and
infected cell density.
Determination of glucose and oxygen uptake rates of 
uninfected Escherichia coli C-3000 cells
Changes in the glucose concentration of the medium were
used to determine the glucose uptake rate of uninfected
Escherichia coli C-3000 cells in minimal M9 media. Cell
density and glucose concentration data were fitted to the
following set of differential equations -
dX
dt
X = m (2)
dS
dt
kX glu =− (3)BMC Systems Biology 2009, 3:121 http://www.biomedcentral.com/1752-0509/3/121
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where X is the cell density, S is the glucose concentration,
μ is the growth rate of the cells and kglu is the glucose
uptake rate of the cells.
Similarly, oxygen uptake rate of uninfected Escherichia coli
C-3000 cells in minimal M9 media was determined on
the basis of changes in the dissolved oxygen concentra-
tions. Cell density and dissolved oxygen concentration
data was fitted to the following set of differential equa-
tions -
where X is the cell density, μ is the growth rate of the cells,
Soxy is the dissolved oxygen concentration, kLa is the mass
transfer coefficient,   is the saturated oxygen concen-
tration in the medium and koxy is the oxygen uptake rate
of the cells. The first term on the right hand side of (5)
relates to the transfer of atmospheric oxygen into the
medium.
Determination of glucose uptake rate of MS2 infected 
Escherichia coli C-3000 cells
Glucose uptake rate of MS2 infected cells was determined
indirectly with the combination of experimental data and
a mathematical model describing the phage-host dynam-
ics. The technique used in this study is similar to the one
presented previously [22] with minor modifications
described below. Specifically in this version, glucose
uptake rate by infected cells was included.
where X is uninfected cell density, Z is phage-sensitive
uninfected cell density, R is phage-resistant uninfected cell
density, Y is phage-infected cell density, P is free phage
density and S is substrate (glucose) concentration.
The Berkeley Madonna software package (version 8.3.14)
[23] was used to estimate parameters in the determination
of glucose and oxygen uptake rates of uninfected cells and
glucose uptake rate of infected cells.
Results and Discussion
Experimental results
The growth rate of the uninfected Escherichia coli C-3000
in minimal M9 media was found to be 0.65 ± 0.02 h-1 (n
= 5). The glucose uptake rate of the uninfected cells was 12
± 0.5 mmol/(g DW h) (n = 3) and the oxygen uptake rate
was 27 ± 1 mmol/(g DW h) (n = 2). The glucose uptake
rate of the MS2-infected Escherichia coli C-3000 cells in
minimal M9 media was the same as that of the uninfected
cells, 12 ± 1 mmol/(g DW h) (n = 3). See Additional file 1
for the original data that was used to determine the above
mentioned cell properties.
Infected Escherichia coli model
The results of the genome-scale model of the infected cell
predicted the flux of the viral coat protein production to
be 4.12 × 10-2 mmol/g DW h and the flux variability anal-
ysis showed no variation in this value. The experimentally
calculated value of the flux, 1.05 × 10-5 mmol/g DW h, was
based on the burst size of 10 ± 1 pfu/cell [22], latent
period of 60 ± 2 min [22] and the composition of the viral
capsid containing 180 copies of the coat protein. The dis-
crepancy between the experimentally calculated value and
the model prediction may be explained by the fact that the
experimentally calculated value only accounts for the
plaque forming units (pfu). It does not account for the
defective MS2 viral particles that are also produced in host
cells [24-27] and are incapable of forming plaques.
Although, no literature was found regarding the particle to
pfu ratio of MS2, studies have reported particle to pfu
ratios of bacteriophage f2, very closely related to MS2, that
range from 7 to 39 [28,29]. In addition, the experimen-
tally measured burst size assumed that all infected cells
dX
dt
X = m (4)
dSoxy
dt
kaS S k X L oxy
sat
oxy oxy =− − () (5)
Soxy
sat
dZ
dt
Zk P Zk Z Z =−− m 12 (6)
dR
dt
Rk R R =− m 6 (7)
dY
dt
kP Z kY U =− 13 (8)
dP
dt
kY U kP Z kP =− − 415 (9)
U  for t latent period
1 for t latent period
=≤ 0
=>
(10)
dS
dt
ZZ
YZS
RR
YRS
kY =
−
−−
mm
//
7 (11)
m
m
Z
ZS
KSZ S
=
+
max,
,
(12)
m
m
R
RS
KSR S
=
+
max,
,
(13)
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produced plaque forming units and an average number of
progeny virus particles were calculated on a per cell basis.
In contrast, studies specific to MS2 bacteriophage and the
use of minimal media have reported that the fraction of
infected cells producing plaque forming units (infective
phages) is as low as 0.01 [24,30,31]. This suggests that the
average burst size may further be increased by as much as
two orders of magnitude. Based on these findings, overall,
the burst size could be increased by three orders of magni-
tude increasing the experimentally calculated value of the
coat protein production flux by three orders of magni-
tude. This may account for the differences between the
experimentally measured value and the model prediction
of coat protein production flux.
Comparison of the infected and uninfected cell 
metabolomes
A comparison of the major pathways in the infected cell
metabolome was made with those in the uninfected cell
metabolome. Flux variability analysis showed no variabil-
ity in the fluxes of the pathways discussed below - both in
the uninfected and the infected models.
The infected cell model predicted that the host cell does
not grow. The value of the flux corresponding to the bio-
mass production was zero, which is consistent with the
experimental observations of MS2/C-3000 viral dynamics
[22]. It was also noted that all the cell wall synthesis and
membrane lipid metabolism reactions were deactivated.
This result also contributes to the fact that the biomass
growth rate was zero and this weakening of the cell wall
may further aid the virus in the lysis of the host at the end
of the infection cycle.
All metabolic resources were diverted to the biosynthesis
of amino acids in the infected cells instead of the produc-
tion of biomass as in the uninfected cells. Overall, there
was anywhere from little change to a five-fold increase in
the biosynthesis of amino acids except for aspartate (D),
Comparison of the biosynthesis of amino acids in a MS2  phage-infected Escherichia coli cell with an uninfected  Escherichia coli cell Figure 1
Comparison of the biosynthesis of amino acids in a 
MS2 phage-infected Escherichia coli cell with an unin-
fected Escherichia coli cell. Little change to a five-fold 
increase was seen although aspartate (D), glutamine (Q), gly-
cine (G) and serine (S) biosynthesis rates decreased by as 
much as two-fold. The x-axis labels represent the single let-
ter amino acid abbreviations, a key for which is available at 
http://en.wikipedia.org/wiki/Amino_acid. Figure legend text.
Comparison of the pentose phosphate pathway in an unin- fected Escherichia coli cell and a MS2 phage-infected  Escherichia coli cell Figure 2
Comparison of the pentose phosphate pathway in an 
uninfected Escherichia coli cell and a MS2 phage-
infected Escherichia coli cell. Relative to uninfected cells, 
all the reactions involved in the pentose phosphate pathway 
were upregulated during infection. (A) Schematic representa-
tion of the pentose phosphate pathway. Words in red repre-
sent metabolites. Rectangular boxes represent reactions, the 
key for which is provided in the Table 2. The numbers in the 
circle represent the flux values of the corresponding reac-
tions in uninfected cell (top value) and infected cell (bottom 
value). (B) Quantitative representation of variation in the 
uninfected and infected cell fluxes of the pentose phosphate 
pathway. Key to the x-axis labels is given in the Table 2.BMC Systems Biology 2009, 3:121 http://www.biomedcentral.com/1752-0509/3/121
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Table 2: List of bacterial reactions and metabolites.
Name Description
Reactions
Pentose Phosphate Pathway (Figure 2)
G6PDH2r g6p + nadp → 6pgl + h + nadph
PGL 6pgl + h2o → 6pgc + h
GND 6pgc + nadp → co2 + nadph + ru5p-D
RPE ru5p-D → xu5p-D
RPI ru5p-D → r5p
TKT1 r5p + xu5p-D → g3p + s7p
TKT2 e4p + xu5p-D → f6p + g3p
TALA g3p + s7p → e4p + f6p
Glycolytic Pathway (Figure 3)
GLCptspp glc-D + pep → g6p + pyr
HEX1 glc-D + atp → g6p + adp + h
PGI g6p → f6p
PFK atp + f6p → adp + fdp + h
FBA fdp → dhap + g3p
GAPD g3p + nad + pi → 13dpg + h + nadh
PGK 13dpg + adp → 3pg + atp
PGM 3pg → 2pg
ENO 2pg → h2o + pep
TCA Cycle (Figure 4)
CS accoa + h2o + oaa → cit + coa + h
ACONTa cit → acon-C + h2o
ACONTb acon-C + h2o → icit
ICDHyr icit + nadp → akg + co2 + nadph
AKGDH akg + coa + nad → co2 + nadh + succoa
SUCOAS adp + pi + succoa → atp + coa + succ
SUCDi q8 + succ → fum + q8h2
FUM fum + h2o → mal-L
MDH mal-L + nad → h + nadh + oaa
Metabolites
13dpg 3-Phospho-D-glyceroyl phosphate
2pg D-Glycerate 2-phosphate
3pg 3-Phospho-D-glycerate
6pgc 6-Phospho-D-gluconate
6pgl 6-phospho-D-glucono-1,5-lactone
Accoa Acetyl-CoA
acon-C cis-Aconitate
Adp Adenosine diphosphate
Akg 2-Oxoglutarate
Atp Adenosine triphosphate
Cit Citrate
co2 Carbon dioxide
Coa Coenzyme A
Dhap Dihydroxyacetone phosphate
e4p D-Erythrose 4-phosphate
f6p D-Fructose 6-phosphate
Fad Flavin adenine dinucleotide
fadh2 Flavin adenine dinucleotide - reduced
Fdp D-Fructose 1,6-bisphosphate
Fum Fumarate
g3p Glyceraldehyde 3-phosphate
g6p D-Glucose 6-phosphate
glc-D D-Glucose
HH +
h2o WaterBMC Systems Biology 2009, 3:121 http://www.biomedcentral.com/1752-0509/3/121
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glutamine (Q), glycine (G) and serine (S) synthesis rates
as shown in Figure 1. Biosynthesis of aspartate, glutamine,
glycine and serine was downregulated as, in addition to
protein synthesis, these amino acids also took part in the
ATP biosynthesis that by itself was downregulated as a
result of change in the objective of the metabolic network.
Also, the pentose phosphate pathway was upregulated
from anywhere between two-fold to 100-fold as shown in
Figure 2.
The glycolytic pathway remained at almost the same levels
as that in the uninfected cells, shown in Figure 3. The only
exceptions were a less than two-fold decrease in the flux
GLCPTS, four-fold increase in the flux HEX1, both reac-
tions corresponding to the conversion of glucose to glu-
cose-6-phosphate and a three-fold decrease in the flux
PGI, corresponding to the conversion of glucose-6-phos-
phate to fructose-6-phosphate. In contrast, the TCA cycle
was severely downregulated, by as much as four to six-
fold, as shown in Figure 4. Some of the reactions were
completely deactivated.
All of these observations may be explained by linking the
metabolic pathways and comparing the metabolic net-
works of the uninfected and the infected cells, as shown in
Figure 5. In an uninfected cell (Figure 5), glucose is taken
up and in the process is converted to glucose-6-phosphate
through two reactions - the phosphotransferase system
reaction (GLCPTS) and the hexokinase reaction. The hex-
okinase reaction requires ATP as a reagent and is therefore
minimized in accordance with the objective function.
Major portion of the glucose taken up is used in the
GLCPTS reaction. Also, a major portion of the glucose-6-
phosphate formed feeds into the glycolytic pathway.
However, a minor portion of glucose-6-phosphate is
diverted towards the pentose phosphate pathway. Most of
the by-products of the pentose phosphate pathway lead
back into the glycolytic pathway. In addition, the pentose
phosphate pathway is a major contributor to the produc-
tion of NADPH, a mediator that is required for the biosyn-
thesis of many amino acids.
The changes in the infected cell may be attributed to the
up-regulation of biosynthesis of amino acids, as shown in
Figure 5. The glucose uptake rates of uninfected and
infected cells are similar. A change in the objective func-
tion removes the constraints on the usage of ATP that
leads to the up-regulation of the hexokinase reaction and
the down-regulation of the GLCPTS reaction. However,
these changes do not affect the amounts of glucose-6-
phosphate, which remains the same in both uninfected
and infected cells. The changes start with the division of
glucose-6-phosphate. The major portion of glucose-6-
phosphate is diverted towards the pentose phosphate
pathway, leading to the up-regulation of the pentose
phosphate pathway. As a result more NADPH is produced
that leads into the up-regulation of biosynthesis of amino
acids. Only a minor portion of glucose-6-phosphate feeds
the glycolytic pathway leading to the down-regulation of
the PGI reaction. Other reactions downstream of the glyc-
olytic pathway are not affected because the up-regulation
of the pentose phosphate pathway increases the amounts
of the by-products of the pentose phosphate pathway,
fructose-6-phosphate and glyceraldehyde 3-phosphate,
which are fed back into the glycolytic pathway.
The increase in biosynthesis of amino acids also has an
effect on the TCA cycle, as shown in Figure 6. In an unin-
fected cell, pyruvate is converted to acetyl-CoA that in-
turn feeds the TCA cycle. Pyruvate and α-ketoglutarate
also act as pre-cursors for the biosynthesis of amino acids.
In infected cells, the up-regulation of amino acid biosyn-
thesis leads to the diversion of a major part of pyruvate to
the biosynthesis process. As a result, smaller amounts of
Icit Isocitrate
mal-L L-Malate
Nad Nicotinamide adenine dinucleotide
Nadh Nicotinamide adenine dinucleotide - reduced
Nadp Nicotinamide adenine dinucleotide phosphate
Nadph Nicotinamide adenine dinucleotide phosphate - reduced
Oaa Oxaloacetate
Pep Phosphoenolpyruvate
Pi Phosphate
Pyr Pyruvate
q8 Ubiquinone-8
q8h2 Ubiquinol-8
r5p alpha-D-Ribose 5-phosphate
ru5p-D D-Ribulose 5-phosphate
s7p Sedoheptulose 7-phosphate
Succ Succinate
Succoa Succinyl-CoA
xu5p-D D-Xylulose 5-phosphate
Table 2: List of bacterial reactions and metabolites. (Continued)BMC Systems Biology 2009, 3:121 http://www.biomedcentral.com/1752-0509/3/121
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acetyl-CoA are formed leading to the severe down-regula-
tion of the TCA cycle. The amount of α-ketoglutarate
formed is inadequate and just enough to act as the pre-
cursor for the biosynthesis of amino acids but not enough
to resume as a part of the TCA cycle. It is here that the TCA
cycle breaks down leading to the deactivation of the reac-
tions downstream. The activity of the last two reactions,
FUM and MDH, in the TCA cycle is only due to the forma-
tion of fumarate as a by-product of other reactions. Even
so, these reactions are markedly downregulated.
Conclusions
A systems biological approach was taken to investigate the
effects of viral infection on the host metabolism. It was
Comparison of the glycolytic pathway in an uninfected  Escherichia coli cell and a MS2 phage-infected Escherichia coli  cell Figure 3
Comparison of the glycolytic pathway in an unin-
fected Escherichia coli cell and a MS2 phage-infected 
Escherichia coli cell. All the reactions were unchanged 
except GLCPTS and HEX1, that correspond to the conver-
sion of glucose to glucose-6-phosphate (g6p) and PGI, that 
corresponds to the conversion of g6p to fructose-6-phos-
phate. (A) Schematic representation of the glycolytic path-
way. Words in red represent metabolites. Rectangular boxes 
represent reactions, the key for which is provided in the 
Table 2. The numbers in the circle represent the flux values 
of the corresponding reactions in uninfected cell (top value) 
and infected cell (bottom value). (B) Quantitative representa-
tion of variation in the uninfected and infected cell fluxes of 
the glycolytic pathway. Key to the x-axis labels is given in the 
Table 2.
Comparison of the TCA cycle in a MS2 phage-infected  Escherichia coli cell with an uninfected Escherichia coli cell Figure 4
Comparison of the TCA cycle in a MS2 phage-
infected Escherichia coli cell with an uninfected 
Escherichia coli cell. Most of the reactions were downregu-
lated by four to six folds and some of them were even deac-
tivated. (A) Schematic representation of the TCA cycle. 
Words in red represent metabolites. Rectangular boxes rep-
resent reactions, the key for which is provided in the Table 2. 
The numbers in the circle represent the flux values of the 
corresponding reactions in uninfected cell (top value) and 
infected cell (bottom value). (B) Quantitative representation 
of variation in the uninfected and infected cell fluxes of the 
TCA cycle. Key to the x-axis labels is given in the Table 2.BMC Systems Biology 2009, 3:121 http://www.biomedcentral.com/1752-0509/3/121
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seen that the viral infection alters the host metabolism to
upregulate the biosynthesis of amino acids. Resources
were diverted away from the TCA cycle and from the syn-
thesis of cell wall components in order to upregulate the
pentose phosphate pathway. This finally resulted in the
production of viral proteins. Interestingly, a similar phe-
nomenon has been noted in cancer cells where glucose is
used primarily for anabolic processes via the pentose
phosphate pathway [32,33], suggesting the use of the E.
coli/MS2 system as a potential test bed for the study of
drugs targeting metabolism for the treatment of cancer.
Clearly, however, any such approach would require far
more rigorous study of the commonalities between the
viral infection process and cancer metabolism before any
real parallels can be drawn.
This study is a proof of principle where techniques of
modeling the metabolic system of a virus-infected host
were described. Incorporation of regulated viral gene
expression, viral genome replication and a suitable objec-
tive function to model an infected cell were shown. The
greatest advantage of this approach is that the effects can
Comparison of metabolic networks of an uninfected and a  MS2 phage-infected Escherichia coli cell Figure 5
Comparison of metabolic networks of an uninfected 
and a MS2 phage-infected Escherichia coli cell. Thick 
flux arrows represent high reaction fluxes, whereas the thin-
ner flux arrows represent low reaction fluxes. Biosynthesis 
of amino acids is upregulated in infected cells. NADPH is a 
pre-cursor that is required in the biosynthesis of most of the 
amino acids. The pentose phosphate pathway provides 
NADPH and is therefore upregulated in infected cells. This 
up-regulation is due to the diversion of a major portion of 
glucose-6-phosphate (g6p) to the pentose phosphate path-
way instead of the glycolytic pathway. The glycolytic pathway 
is not affected because the loss of g6p is made up by the gain 
in the amounts of the by-products of the pentose phosphate 
pathway, fructose-6-phosphate and glyceraldehyde 3-phos-
phate, which are fed back into the glycolytic pathway.
Comparison of TCA cycle of an uninfected and a MS2 phage- infected Escherichia coli cell Figure 6
Comparison of TCA cycle of an uninfected and a MS2 
phage-infected Escherichia coli cell. Thick flux arrows 
represent high reaction fluxes, whereas the thinner flux 
arrows represent low reaction fluxes. Biosynthesis of amino 
acids is upregulated in infected cells leading to the diversion 
of pyruvate to the biosynthesis of amino acids. As a result, 
the conversion of pyruvate to acetyl-CoA is downregulated. 
This severely downregulates the TCA cycle. The amount of 
α-ketoglutarate formed is just enough to act as the pre-cur-
sor for the biosynthesis of amino acids. This is where the 
TCA cycle breaks leading to the deactivation of the reactions 
downstream (represented by red crosses). The activity of 
the last two reactions in the TCA cycle is only due to the 
formation of fumarate as a by-product of other reactions. 
Even so, these reactions are markedly downregulated.BMC Systems Biology 2009, 3:121 http://www.biomedcentral.com/1752-0509/3/121
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be seen at full genome-scales. Advances in both experi-
mental and computational fields could be used to extend
this work to higher order organisms. Efforts to model
human cellular metabolism are taking place [34-36] and
application of the methods described in the current study
may give new insights. Information based on the up-regu-
lation and down-regulation of certain reactions could
then be utilized to draw new treatment strategies.
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